Summary
Alloxan diabetes promotes, in the rabbit, decrease in sensitivity to norepinephrine (NOR) in the isolated iris dilator muscle at 25 and 37°C in vitro.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
J.L. Matheny and R.P. Ahlquist, Archs int. Pharmacodyn. Thér.209, 197 (1974).
M.C. Fonteles and A.M. Karow, Jr., Archs int. Pharmacodyn. Thér.223, 196 (1976).
R. Tirri and A. Siltuvuori, Experientia33, 922 (1977).
G. Kunos and M. Szentiványi, Nature217, 1077 (1968).
M. Szentiványi and L. Pek, Nature243, 277 (1973).
R. Kern, Arch. Klin. Exp. Ophthal.180, 231 (1970).
A. Hartel, Z. klin. Chem.6, 34 (1968).
R. Cseuz, T.L. Wenger, G. Kunos and M. Szentiványi, Endocrinology,93, 1752 (1973).
G. Kunos, M.S. Yong and M. Nickerson, Nature241, 119 (1973).
M.J. Brody and R.L. Dixon, Circulation Res.14, 494 (1964).
A. Costa e Forti and M.C. Fonteles, submitted.
A.R. Christlieb, H.-U. Janka, B. Kraus, R.E. Cleason, E.A. Icasas-Cabral, B.V. Cabral and A. Solano, Diabetes25, 268 (1975).
R.P. Ahlquist, Fed. Proc.36, 2572 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fonteles, M.C., Matheny, J.L. α-Adrenoceptor alteration by alloxan diabetes in iris dilator muscle of the rabbit. Experientia 35, 633 (1979). https://doi.org/10.1007/BF01960366
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01960366